|Products & Services
|CryoValve® SG Pulmonary Human Heart Valve Resource Library|
The SynerGraft Process Animation
CryoLife's proprietary SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from the valve without compromising the integrity of the underlying collagen matrix.
Candy Murray Testimonial
Candy Murray received a CryoValve SG Pulmonary Heart Valve in 2000. The results of her surgery were part of the data that was given to the FDA in order for CryoLife to receive clearance for the valve. Please note that this is Ms. Murray's personal testimony and individual results may vary.
Dr. John J. Lamberti and Dr. Paul E. Stelzer
John J. Lamberti, M.D. is the Eugene and Joyce Klein Director of the Heart Institute at Rady Children's Hospital - San Diego and a Professor of Surgery at the University of California San Diego Medical School.
Paul E. Stelzer, M.D. is Senior Faculty of Cardiothoracic Surgery at Mount Sinai School of Medicine in New York, New York.
Hawkins JA, et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg2003 Jul;126(1):247-52; discussion 252-3